Glutamate Dehydrogenase 1/2 Antibody

About the Target

Glutamate Dehydrogenase 1/2 is a target of interest in many antibody-based workflows. Glutamate dehydrogenase (GDH) is a mitochondrial enzyme that catalyzes the reversible conversion of glutamate to α-ketoglutarate and ammonia while reducing NAD(P)+ to NAD(P)H, contributing to energy production, redox homeostasis, and cell signaling. GDH is a hexameric structure with two sets of trimers, each monomer containing binding sites for GTP, ADP, and NADH. Depending on the literature source, Glutamate Dehydrogenase 1/2 may also be discussed as GLUD1 + GLUD2.

Reported cellular context includes endoplasmic reticulum and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following Glutamate Dehydrogenase 1/2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

Glutamate Dehydrogenase 1/2 is commonly interpreted in the context of neuroscience and metabolism research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endoplasmic reticulum and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between endoplasmic reticulum and mitochondrion across matched conditions
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Glutamate Dehydrogenase 1/2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Glutamate Dehydrogenase 1/2 reflect biology rather than handling. When interpreting Glutamate Dehydrogenase 1/2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Glutamate Dehydrogenase 1/2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.